Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
87
Views
40
CrossRef citations to date
0
Altmetric
Original Research

Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer

Yiqun Shao1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
,
Wenjing Zhu2 Department of Urology, Yueyang Hospital of integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
,
Jun Da1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
,
Mingxi Xu1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
,
Yiwei Wang1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
,
Juan Zhou1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
&
Zhong Wang1 Department of Urology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2675-2683 | Published online: 22 May 2017

References

  • VannemanMDranoffGCombining immunotherapy and targeted therapies in cancer treatmentNat Rev Cancer201212423725122437869
  • KamatAMHahnNMEfstathiouJABladder cancerLancet2016388100612796281027345655
  • DoninNMLenisATHoldenSImmunotherapy for the treatment of urothelial carcinomaJ Urol20171971142227460757
  • WangXTengFKongLYuJPD-L1 expression in human cancers and its association with clinical outcomesOnco Targets Ther201695023503927574444
  • InmanBASeboTJFrigolaXPD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progressionCancer200710981499150517340590
  • PowlesTEderJPFineGDMPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerNature2014515752855856225428503
  • RosenbergJEHoffman-CensitsJPowlesTAtezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialLancet2016387100311909192026952546
  • LuYMiaoLWangYCurcumin micelles remodel tumor microenvironment and enhance vaccine activity in an advanced melanoma modelMol Ther201624236437426334519
  • ZhouJDonatelliSSGilvaryDLTherapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterinSci Rep201662952127405665
  • BillMABakanCBensonDJJrFuchsJYoungGLesinskiGBCurcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokinesMol Cancer Ther2009892726273519723881
  • LiuHXuHJiangYPreparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targetingInt J Nanomedicine2015106395641026504386
  • BasileVFerrariELazzariSBellutiSPignedoliFImbrianoCCurcumin derivatives: molecular basis of their anti-cancer activityBiochem Pharmacol200978101305131519580791
  • BhattacharyyaSMandalDSahaBSenGSDasTSaGCurcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 inductionJ Biol Chem200728222159541596417392282
  • BaoBAhmadALiYTargeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cellsExpert Opin Ther Targets201216101041105422877147
  • JiangGMXieWYWangHSCurcumin combined with FAPalphac vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-alpha in melanomaOncotarget2015628259322594226305550
  • ZouWWolchokJDChenLPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsSci Transl Med20168328324r328r
  • LiBZhuXSunLInduction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcomaOncotarget2014521107911080225301731
  • DufaitISchwarzeJKLiechtensteinTEx vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerOncotarget2015614123691238225869209

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.